CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 10-K/A Report 10-K/A
- 8-K/A Event Exhibits
- 8-K Event Material agreement · Executive or director change
- DEF 14A Proxy Proxy Statement
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- NT 10-Q Other NT 10-Q
- 10-K Report Annual Report
- 8-K Event Results of operations
- NT 10-K Other NT 10-K
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
Page 64 of 77 · 1,525 filings